depression on tirzepatide GLP-1s linked to lower rates of anxiety and than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Tirzepatide not linked to increased

These drugs, which stimulate insulin release and reduce appetite, offer promising therapeutic options for managing blood sugar levels and supporting weight loss in individuals with these conditions

Similar to GLP-1 receptors, amylin receptors are also in areas of the brain related to appetite, and stimulating them sends messages that youre not hungry, Drucker says

During a nationwide shortage, the FDA temporarily allowed certain compounded versions of GLP-1 medications

Even a modest weight loss of 5-10% has been shown to have a significant impact on reducing systemic inflammation, making GLP-1 medications a powerful tool for not only achieving weight loss but also improving inflammatory markers

A particularly informative pharmacological example is provided by the diazepine derivative YL3147, a highly potent radical-trapping antioxidant that directly interrupts the chain-propagation phase of lipid peroxidation and confers robust protection in both acute and chronic murine models of doxorubicin-induced cardiomyopathy

LRD, ISL, QCZ, JLW, JET, DJP, and DG collected and analyzed data and revised the manuscript